Skip to content
DraconiticResearch
Search Sources API
190,851 studies31 sourcesUpdated 17 min ago
PreprintAll rights reservedmedRxiv

Host Determinants of Adjuvant Chemotherapy Initiation and Survival in Upper Gastrointestinal Adenocarcinoma

3 more authors
  1. 1Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre

Related

  1. Interaction between severe postoperative complications and adjuvant chemotherapy on overall survival after upfront resection of pancreatic ductal adenocarcinoma.
    Shiwei Wu, Daobin Wang, Dongxing Zhang +5
    Frontiers in medicinePeer-reviewedCC BYFull textOncologyEurope PMC
  2. Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases
    Kozo Kataoka, Kazuma Ito, Yoshiaki Nakamura +35
    JAMA OncologyPeer-reviewedLicence not stated10 citedOncologyOpenAlex
  3. History of gastrointestinal symptoms with other glucose‐lowering agents is associated with gastrointestinal adverse events after imeglimin initiation: A retrospective real‐world study
    Kodai Yoshida, Yukiko Onishi, Tetsuya Kubota +7
    Journal of diabetes investigationPeer-reviewedCC BY-NCFull textEndocrinology & metabolismEurope PMC
  4. Longitudinal Association Between the Change in Serum Procollagen Type III N-Terminal Peptide (PIIINP) and Skeletal Muscle Loss in Patients with Gastrointestinal Cancer Receiving Chemotherapy: A Prospective Cohort Study
    Mehmet Erdinç Esenkaya, Özlem Özdemir, Mustafa Değirmenci +3
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
  5. Patient-reported Symptom Resolution After Neoadjuvant Versus Adjuvant Chemotherapy for Early Breast Cancer: A Prospective Observational Cohort Study
    TAKAAKI FUJII, KEI ICHIBA, MAYU AOKI +4
    In VivoPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
BibTeX
@misc{jiao2026host,
  title = {{Host Determinants of Adjuvant Chemotherapy Initiation and Survival in Upper Gastrointestinal Adenocarcinoma}},
  author = {B. Jiao and S. Alotaibi and K. Abumelha and J. Tankel and L. Ferri and J. Asselah and T. Alcindor and C. Mueller and M. Rousseau and S. Soldera and L. Lee and N. Bertos and M. Dehghani and K. A. Ma and J. Cools-Lartigue},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.13.26365477},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.13.26365477v1},
}
RIS
TY  - UNPB
TI  - Host Determinants of Adjuvant Chemotherapy Initiation and Survival in Upper Gastrointestinal Adenocarcinoma
AU  - B. Jiao
AU  - S. Alotaibi
AU  - K. Abumelha
AU  - J. Tankel
AU  - L. Ferri
AU  - J. Asselah
AU  - T. Alcindor
AU  - C. Mueller
AU  - M. Rousseau
AU  - S. Soldera
AU  - L. Lee
AU  - N. Bertos
AU  - M. Dehghani
AU  - K. A. Ma
AU  - J. Cools-Lartigue
PY  - 2026
DA  - 2026/10/13
PB  - medRxiv
DO  - 10.64898/2026.10.13.26365477
UR  - https://www.medrxiv.org/content/10.64898/2026.10.13.26365477v1
ER  -